EcoR1 Capital’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-88,569
| Closed | -$731K | – | 37 |
|
|
2025
Q1 | $731K | Sell |
88,569
-167,004
| -65% | -$1.38M | 0.04% | 43 |
|
|
2024
Q4 | $10.2M | Hold |
255,573
| – | – | 0.38% | 39 |
|
|
2024
Q3 | $2.21M | Sell |
255,573
-6
| -0% | -$52 | 0.08% | 55 |
|
|
2024
Q2 | $2.24M | Hold |
255,579
| – | – | 0.07% | 53 |
|
|
2024
Q1 | $6.26M | Hold |
255,579
| – | – | 0.16% | 49 |
|
|
2023
Q4 | $4.24M | Buy |
255,579
+97,645
| +62% | +$1.62M | 0.11% | 39 |
|
|
2023
Q3 | $2.95M | Hold |
157,934
| – | – | 0.1% | 41 |
|
|
2023
Q2 | $3.83M | Hold |
157,934
| – | – | 0.09% | 41 |
|
|
2023
Q1 | $3.45M | Hold |
157,934
| – | – | 0.11% | 41 |
|
|
2022
Q4 | $3.76M | Hold |
157,934
| – | – | 0.11% | 51 |
|
|
2022
Q3 | $4.34M | Hold |
157,934
| – | – | 0.13% | 52 |
|
|
2022
Q2 | $4.78M | Hold |
157,934
| – | – | 0.16% | 47 |
|
|
2022
Q1 | $8.49M | Buy |
157,934
+154,292
| +4,236% | +$8.29M | 0.27% | 44 |
|
|
2021
Q4 | $1.08M | Buy |
+3,642
| New | +$1.08M | 0.03% | 63 |
|